Fig. 1From: Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn’s disease: a case reportEndoscopic findings of longitudinal, serpiginous ulcerations along the entirety of the esophagus consistent with an esophageal manifestation of Crohn’s disease. Our patient was on adalimumab and mesalamine at the timeBack to article page